Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates - Pavot, Vincent; Berry, Catherine; Kishko, Michael; Anosova, Natalie G.; Huang, Dean; Tibbitts, Tim; Raillard, Alice; Gautheron, Sylviane; Gutzeit, Cindy; Koutsoukos, Marguerite; Chicz, Roman M.; Lecouturier, Valerie (Nature communications, 2022)
Keywords: 13/1; 631/250/590/2294; 631/326/596/4130; 692/308/2778; 692/699/255/2514; Animals; Antibodies; Antibodies, Viral; Clinical trials; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines; Cross-protection; Humanities and Social Sciences; Humans; mRNA; multidisciplinary; Neutralization; Neutralizing; Primates; Proteins; SARS-CoV-2 - genetics; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus; Spike protein; Vaccine efficacy; Vaccines; Viral diseases; Viral Vaccines